Hans-Peter Hartung
33PUBLICATIONS
99CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (33)
Sort by Publication Date:
|Dec 15, 2025
Cellular and humoral vaccination response under immunotherapies-German consensus on vaccination strategies in neurological autoimmune diseases.Muriel Schraad, Mathias Mäurer, Anke Salmen
|Jul 17, 2025
Serum Alpha-Linolenic Acid and Long-Term Multiple Sclerosis Activity and Progression.Marianna Cortese, Xiaojing Peng, Gilles Edan
|Apr 25, 2025
SARS-CoV-2 Vaccines and Multiple Sclerosis: An Update.Tobias Monschein, Tobias Zrzavy, Paulus S Rommer
|Apr 11, 2025
Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple Sclerosis.Alice G Willison, Ramona Hagler, Margit Weise
|Dec 03, 2024
Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis: The Phase IIIb ENSEMBLE 4-Year, Single-Arm, Open-Label Trial.Hans-Peter Hartung, Ralph H B Benedict, Thomas Berger
|Nov 25, 2024
Different Treatment Outcomes of Multiple Sclerosis Patients Receiving Ocrelizumab or Ofatumumab.Sven G Meuth, Stephanie Wolff, Anna Mück
Pageof 6
Frequent Collaborators
3 joint publications
Ralf Gold
3 joint publications
Thomas Berger
3 joint publications
Ludwig Kappos
3 joint publications
Alice G Willison
3 joint publications
Bruce A C Cree
3 joint publications
Sven G Meuth
2 joint publications
Ralf Linker
2 joint publications
Gen Sobue
2 joint publications
Tania Kümpfel
2 joint publications
Tobias Ruck
